Fairmount Funds Management LLC - Director, 10%+ Owner at CRESCENT BIOPHARMA, INC.

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Issuer Symbol
CBIO on Nasdaq
All Insider Reports
All Insider Reports

Fairmount Funds Management LLC - trading volume in the past year for CRESCENT BIOPHARMA, INC.

Holdings reported by Fairmount Funds Management LLC for CRESCENT BIOPHARMA, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Ordinary Shares 2,747,866 $36,848,883 $13.41 04 Dec 2025 By Fairmount Healthcare Fund II L.P.
Pre-Funded Warrant (Right to Buy) 1,768,140 $23,708,989 $13.41 04 Dec 2025 By Fairmount Healthcare Fund II L.P. Ordinary Shares
Stock Option (Right to Buy) 9,023 23 Jun 2025 By: Peter Harwin Ordinary Shares

Transactions reported by Fairmount Funds Management LLC for CRESCENT BIOPHARMA, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.